Andrew Mendiola, PhD, is an Assistant Professor in the Department of Pharmacology at the University of California San Diego. He has experience in disease-focused neuroimmunology and neurovascular biology, transcriptional regulation, genomics, and bioinformatics. Andrew’s research focuses on investigating triggers and epigenetic mechanisms governing brain innate immune cell dysfunction, with the goal to develop novel cell- and function-specific therapies for neurologic diseases. His laboratory integrates systems neuroimmunology, multiomics with computational biology, mouse models and tissue culture, functional genomics with CRISPR, immune profiling and sorting via flow cytometry, histopathology, and biochemistry techniques, as a multifaceted experimental approach to address the biological complexity of microglial functions in neurologic diseases such as multiple sclerosis and Alzheimer’s disease.
Prior to joining UCSD, Andrew received his PhD in cellular and molecular biology from the University of Texas at San Antonio. He then went on to complete a NMSS- and NIH-funded postdoctoral fellowship at the Gladstone Institutes, University of California San Francisco.
Andrew received many honors & awards for his research and scholarship including a NIH Pathway to Independence Award (MOSAIC K99/R00), a National Multiple Sclerosis Society Postdoctoral Fellowship, and a 2020 Dorman Prize for best postdoc publication at Gladstone Institutes.